Innovassynth Technologies reports PAT of INR 1196 lakh in Q4FY26
Innovassynth Technologies (India) Limited posted a PAT of INR 1196 lakh for Q4FY26, reversing the loss from the prior quarter. Revenue reached INR 5083 lakh, supported by an INR 60 crore increase in the order book. The company cited transitory logistics issues and inventory adjustments for recent volatility but expects improved performance driven by capacity expansion and a robust CDMO pipeline.
*this image is generated using AI for illustrative purposes only.
Innovassynth Technologies (India) Limited reported a Profit After Tax (PAT) of INR 1196 lakh for the quarter ended March 31, 2026, recovering from a loss of INR 780 lakh in the quarter ended December 31, 2025. Revenue from operations for Q4FY26 stood at INR 5083 lakh, compared to INR 2197 lakh in the previous quarter. The company’s order book improved by approximately INR 60 crore during the period, reflecting continued customer demand and providing enhanced revenue visibility.
The financial results for FY 2025–26 represent the full-year operating performance of the merged entity following the absorption merger effective October 1, 2024. Comparative figures for FY 2024–25 reflect only the post-merger period from October 1, 2024, to March 31, 2025, making the figures for the two periods not directly comparable.
Performance Update and Outlook
Management noted that performance during the previous quarter was impacted by temporary shipment delays due to logistics disruptions from the ongoing Middle East conflict and a one-time inventory adjustment by a key customer. These factors were described as transitory, with no change in the underlying demand environment or business fundamentals. The inventory adjustment is expected to be a one-time event with no material impact on future business volumes.
Strategic Growth Drivers
The company is executing a life sciences capacity expansion expected to double capacity, aligned with CDMO demand growth. It successfully completed audits from two large CDMO customers with no major observations, reinforcing strong quality systems. Two additional customer audits are scheduled in the coming months to support pipeline expansion. The customer base remains diversified across the USA and Europe, reducing geographic concentration risk.
Financial Results
The company reported an EBITDA of INR 628 lakh for Q4FY26, with an EBITDA margin of 12%. For the year ended March 31, 2026, the company reported a net loss of INR 2878 lakh, with revenue from operations at INR 10235 lakh. The open order book as of the reporting period stood at approximately INR 176 crore, with major orders from USA-based companies.
| Particulars | Quarter Ended 31-Mar-2026 | Quarter Ended 31-Dec-2025 | Quarter Ended 31-Mar-2025 |
|---|---|---|---|
| Revenue from operations | 5083 | 2197 | 4841 |
| EBITDA | 628 | (407) | 1040 |
| PAT | 1196 | (780) | 1163 |
| Diluted EPS (INR) | 1.59 | (1.03) | 1.54 |
Amount in INR Lakhs
Historical Stock Returns for Innovassynth Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.99% | +20.19% | +35.40% | +37.38% | +69.90% | +1,102.25% |
What is the projected timeline for the life sciences capacity expansion to reach full operational status?
How will the company utilize the strengthened order book to sustain revenue growth in the upcoming fiscal year?
What impact will the scheduled customer audits have on the company's pipeline expansion and potential new contracts?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
